Status:
COMPLETED
Effectiveness of an Integrated Colorectal Cancer Screening in Saudi Arabia: A Pragmatic Randomized Trial
Lead Sponsor:
University of Tabuk
Collaborating Sponsors:
Ein Al-Hayat Medical Complex
The Charitable Society for Health Care in Tabuk
Conditions:
Colorectal Neoplasms
Colorectal Cancer
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The global burden of colorectal cancer (CRC) incidence among young age groups is rising and overwhelming. This new trend of young-onset CRC incidence is evident in western countries. Unfortunately, As...
Detailed Description
CRC is cancer that starts in the innermost lining mucosa of the colon or rectum. According to the global cancer Observatory (GCO) 2018, CRC incidence is the third (10.2%) globally, after lung and brea...
Eligibility Criteria
Inclusion
- The participants will be individuals with an average risk of colorectal cancer, age: 40 years and above of both genders
Exclusion
- Individuals age less than 40 years or severely ill individuals
Key Trial Info
Start Date :
June 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 10 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04875793
Start Date
June 10 2021
End Date
July 10 2022
Last Update
December 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Public Primary Health Care Centers in the Tabuk City
Tabuk, Saudi Arabia, 71491